**Conflict of interest**

AA has no conflicts of interest.

IC sits on the advisory board for Eli Lilly and Company, Bristol-Myers Squibb, MSD, Bayer, Roche, Merck Serono and Five Prime Therapeutics, Inc. He has received research funding from Eli Lilly and Company, Janssen-Cilag, Sanofi Oncology and Merck Serono and has received an honorarium from Eli Lilly and Company.

*Advances in the Molecular Understanding of Colorectal Cancer*
